PedAM
Pediatric Disease Annotations & Medicines
| Disease | thrombocytosis |
| Symptom | C1264195|refractory anemia with ringed sideroblasts |
| Sentences | 4 |
| PubMedID- 21034166 | Jak2v617f was found among 81.4% of polycythemia vera (pv), 50% of essential thrombocythemia, 46.1% of primary myelofibrosis (pmf), 33.3% of philadelphia (ph)-negative chronic myeloid leukemia, 33.3% of myelodysplastic syndrome (mds)/myeloproliferative neoplasm (mpn), and 50% of refractory anemia with ringed sideroblasts associated with marked thrombocytosis (rars-t) patients. |
| PubMedID- 23401728 | The rars-t subtype (refractory anemia with ringed sideroblasts associated with marked thrombocytosis) is included in the mds / mpn-u as a temporary entity. |
| PubMedID- 24399021 | refractory anemia with ringed sideroblasts associated with marked thrombocytosis (rars-t) was included in this category. |
| PubMedID- 25621045 | The current study presents the case of a 63-year-old patient exhibiting refractory anemia with ringed sideroblasts associated with marked thrombocytosis (rars-t), who was positive for the mpl w515l mutation, but negative for the jak2 v617f mutation. |
Page: 1